@article{c721fab0342e4436976fa6e55fb8b146,
title = "Open-Label Study to Determine the Feasibility of Ixazomib as Maintenance after Allogeneic Stem Cell Transplant for Multiple Myeloma",
author = "Bachier, \{Carlos R.\} and Shaughnessy, \{Paul J.\} and Jeffrey Matous and Berdeja, \{Jesus G.\}",
note = "Background: Allogeneic stem cell transplantation (SCT) for patients (pts) with high-risk multiple myeloma (MM) carries a risk of relapse and graft-versus-host disease (GVHD). Proteasome inhibitors (PI) can stimulate allogeneic immune cells to eliminate MM cells but also reduce the incidence and severity of GVHD.",
year = "2018",
month = mar,
day = "1",
doi = "10.1016/J.BBMT.2017.12.237",
language = "American English",
volume = "24",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1523-6536",
publisher = "Elsevier",
number = "3",
}